A Case of Postpartum Empty Sella: Possible Hypophysitis

Total Page:16

File Type:pdf, Size:1020Kb

A Case of Postpartum Empty Sella: Possible Hypophysitis Endocrine Journal 1993, 40 (4), 431-438 A Case of Postpartum Hypopit uitarism associated with Empty Sella: Possible Relation to Postpartum Autoimmune Hypophysitis SAWA NISHIYAMA, TORU TAKANO, YOH HIDAKA, KAORU TAKADA, YosHINORI IWATANI AND NoBUYUxi AMINO Department o,f Laboratory Medicine, Osaka University Medical School, Suita 565, Japan Abstract. A fifty-year-old woman was admitted to our hospital because of generalized edema, progressive symptoms of fatigue and weakness of ten years' duration. After an uneventful third delivery, 24 years before admission, she could not lactate and developed oligomenorrhea and then amenorrhea. Laboratory evaluation revealed panhypopituitarism and pituitary cell antibodies were positive. Both CT scans and MR images showed empty sella. This case is postpartum hypopituitarism without a preceding history of excessive bleeding and may be autoimmune hypophysitis. Key words: Autoimmune hypophysitis, Postpartum hypopituitarism. (Endocrine Journal 40: 431-438, 1993) AUTOIMMUNE lymphocytic hypophysitis causes Case Report hypopituitarism during late pregnancy and the postpartum period. It was first reported in 1962 as A fifty-year-old woman, gravida 5, para 3, was a postmortem finding [1]. The first case diagnosed referred to our hospital to evaluate possible antemortem was reported in 1980 [2]. In many hypopituitarism. When she was 24 years old, at her reported cases, lymphocytic infiltration of the second delivery, she lost a considerable amount of pituitary gland caused a pituitary mass and symp- blood but she continued to have normal menstrual toms of pituitary dysfunction or chiasmal syn- periods. She uneventfully delivered her third child drome. In other mild cases, pituitary mass effects two years later. After this third delivery, she had were not seen or pituitary dysfunction became no breast engorgement nor could she lactate. Her apparent more than 20 years after delivery. It is menstrual cycle resumed, but only 4 times a year. difficult to distinguish such cases from Sheehan's She went to see a gynecologist and began taking syndrome without pituitary biopsy. There may be combination sex steroid contraceptives. After dis- many mild cases that are overseen or misdi- continuing oral contraceptives in her thirties, she agnosed. became amenorrheic and remained so. She lost We report here a patient who had gradually her pubic and axillary hair gradually, and fatigue, developed postpartum hypopituitarism and dis- weakness, facial and hand puffiness also de- cuss its possible relation to autoimmune hypophy- veloped. For several months preceding admission, sitis. she had become more drowsy and lost 4 kg in weight. She found her voice becoming hoarse. She visited a hospital and she was found to be suffering Received: January 4, 1993 from secondary hypothyroidism. She was referred Accepted: May 7, 1993 Correspondence to: Dr. Sawa NISHIYAMA, Department of to our hospital for further investigation. She had Laboratory Medicine, Osaka University Medical School, 2-2 never suffered from a severe headache accompa- Yamadaoka, Suita 565, Japan nied with visual field disturbance. 432 NISHIYAMA et al. Her height was 149 cm; weight, 48 kg; blood FITC-labeled human IgG solution was added to pressure, 118178 mmHg; and pulse rate, 64 per the cell suspension. The cells were washed again minutes. Her skin was pale and dry. She had no and fluorescence positive cells were counted axillary or pubic hair. Her face was swollen. The (PCSA). thyroid gland was not enlarged. Neurological examination was normal except for delayed re- laxation of deep tendon reflexes. Results Initial laboratory findings showed mild nor- mocytic anemia. Serum cholesterol and trig- Methods lyceride were mildly increased. Serum GOT was To evaluate the pituitary function, provocative also high but GPT and CPK were within the tests were performed during fasting with in- normal range (Table 1). travenous administration of 0.1 U of insulin per Basal serum concentrations of various hor- kilogram of body weight, 500 µg of TRH and 100 mones were as follows; ACTH: <10 pg/ml (nor- µg of LH-RH. Blood samples were drawn before mal range; <50), cortisol: 1.0 µg/dl (normal range; and 30, 60, 90, and 120 min after injection. 4.5-24), GH: <0.3 ng/ml (normal range; <5.0), Arginine (0.5 g per kilogram of body weight) was LH: 0.7 mIU/ml (normal range; 8.7-38), FSH: 4.9 given as an intravenous drip for 30 min, and mIU/ml (normal range; 26.2-113.3), PRL: 1.4 serum GH changes before and 30, 60, 90, and 120 ng/ml (normal range; <15), FT4: 0.2 ng/dl (nor- min after the beginning of the drip were evalu- mal range; 0.8-1.4), FT3: 2.1 pg/ml (normal ated. Every blood hormone was measured by range; 2.8-5.8), TSH: 4.6 µU/ml (normal range; means of a specific RIA; serum TSH was mea- 0.4-5.6). The results of detailed endocrine inves- sured by an IRMA with monoclonal antibody (SPAC-S TSH Kit, Daiichi), serum free T4 (FT4) and free T3 (FT3) by analog RIA (Free T4 Kit, Eiken, and Amerlex-M free T3, Amersham), serum GH by an IRMA (GH Kit, Daiichi), serum ACTH by IRMA (ACTH-II IRMA Kit `Mitsu- bishiyuka', Mitsubishiyuka), serum cortisol by RIA (cortisol Eiken, Eiken), serum LH and FSH by IRMA (SPAC-S LH Kit and SPAC-S FSH Kit, Daiichi), serum PRL by IRMA (SPAC-S PRL Kit, Daiichi). Anti-thyroid microsomal and anti-thyroglobulin antibodies were tested by a passive particle- agglutination method (Serodia-AMC and Serodia- ATG, Fujirebio). Anti-pituitary-antibodies (APA) reacting to rat pituitary cytoplasmic antigens (pituitary cell anti- bodies, PCA) and APA reacting to rat GH3 cells' and mouse AtT20 cells' surface antigens (pituitary cell surface antibodies, PCSA) were assayed by the method of Sugiura et al. [3, 4]. Aliquots of serum, after absorption with rat liver acetone powder, were added to rat pituitary cryostat sections and assayed by a biotin-avidin system (PCA). Heat- inactivated sera, which were also preabsorbed with rat liver acetone powder, were diluted and mixed with GH3 and AtT20 cell suspension, and kept for 30 min at 4 degrees. The cells were washed and POSTPARTUM HYPOPITUITARISM 433 tigations are shown on Figs 1-2. Serum gonado- tropin (LH and FSH) did not respond to LH-RH (Fig. 1A). Serum PRL did not increase after TRH administration, but TSH showed a blunted re- sponse (Fig. 1B). An insulin tolerance test showed no response of ACTH, GH or cortisol (Fig. 2A). The serum GH level did not change at all after arginine infusion (Fig. 2B). Anti-pituitary-antibodies (APA) reacting to rat pituitary cytoplasmic antigens (pituitary cell anti- bodies) were positive, but APA reacting to rat GH3 cells' and mouse AtT2o cells' surface antigens (pituitary cell surface antibodies) were negative. She had neither anti-thyroid microsomal nor anti-thyroglobulin antibodies. Antinuclear anti- bodies were negative, either. Both magnetic resonance (MR) images (Fig. 3A), and computed tomography (CT) scans (Fig. 3B) showed empty sella. The patient was diagnosed as having panhypo- Fig. 2. A: GH, cortisol, and ACTH responses to insulin tolerance test. Hypoglycemia was induced with 0.05 U/kg regular insulin given as an intravenous bolus. B: GH response to arginine. Arginine (0.5 g/kg) was given as an intravenous drip for 30 min. pituitarism. She responded well to thyroid replace- ment and hydrocortisone with resolution of her symptoms. Discussion We treated a patient with postpartum hypopi- tuitarism that developed after her third, unevent- ful delivery. There are three main causes of postpartum hypopituitarism: Pituitary adenoma, Sheehan's syndrome and autoimmune lymphocy- tic hypophysitis. Pituitary microadenoma did not agree with her clinical course, and neither CT scans nor MR images showed pituitary adenoma but empty sella. Although Sheehan's syndrome is so common that many cases with postpartum hypopituitarism are diagnosed as that syndrome, it is difficult to suppose that she suffered from Sheehan's syndrome. She had abnormal bleeding at her second delivery, but she resumed normal Fig. 1. A: LH and FSH responses to LH-RH. B: Prolactin and TSH responses to TRH. LH-RH (100µg) and menstrual cycles and became pregnant with her TRH (500 µg) were given together as an in- third baby. travenous bolus. Recently autoimmune lymphocytic hypophysitis 434 NISHIYAMA et al. has been recognized as a cause of hypopituitarism tis frequently causes ACTH and TSH deficiency. during late pregnancy and the postpartum period. There was sometimes hyperprolactinemia hap- Patients who had symptoms indicating a pituitary pened with a pituitary mass that probably com- mass were operated on and the diagnosis was pressed the adjacent stalk and interfered with the histologically confirmed. On the other hand, there delivery of prolactin-inhibiting factors. was no clinical indication to have a pituitary biopsy It is difficult to know whether or not the patients for patients with pituitary hypofunction without who had pituitary hormone deficiency had reco- pituitary mass effects. Such cases were thought to vered normal pituitary function without biopsy, be "possible autoimmune hypophysitis" with co- because most patients were operated on as soon as existent autoimmune diseases or auto-antibodies. the masses were found. Some patients who had According to her history and the presence of "possible" lymphocytic hypophysitis-hypopi- anti-pituitary-antibodies, she probably had auto- tuitarism and (or) pituitary masses which were not immune lymphocytic hypophysitis which occurred surgically treated-recovered [43, 46], but others after her third delivery. It is difficult to recognize did not [40-42, 44, 45]. such a mild case soon after the onset of the disease, Out of 17 pregnant patients, 14 showed signs of because the symptoms of hypopituitarism are not hemianopia and 6 patients' vision grew worse after distinctive-for example, fatigability, amenorrhea, delivery.
Recommended publications
  • Lymphocytic Hypophysitis Successfully Treated with Azathioprine
    1581 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.74.11.1581 on 14 November 2003. Downloaded from SHORT REPORT Lymphocytic hypophysitis successfully treated with azathioprine: first case report A Lecube, G Francisco, D Rodrı´guez, A Ortega, A Codina, C Herna´ndez, R Simo´ ............................................................................................................................... J Neurol Neurosurg Psychiatry 2003;74:1581–1583 is not well established, but corticosteroids have been An aggressive case of lymphocytic hypophysitis is described proposed as first line treatment.10–12 Trans-sphenoidal surgery which was successfully treated with azathioprine after failure should be undertaken in cases associated with progressive of corticosteroids. The patient, aged 53, had frontal head- mass effect, in those in whom radiographic or neurological ache, diplopia, and diabetes insipidus. Cranial magnetic deterioration is observed during treatment with corticoster- resonance imaging (MRI) showed an intrasellar and supra- oids, or when it is impossible to establish the diagnosis of sellar contrast enhancing mass with involvement of the left lymphocytic hypophysitis with sufficient certainty.25 cavernous sinus and an enlarged pituitary stalk. A putative We describe an unusually aggressive case of pseudotumor- diagnosis of lymphocytic hypophysitis was made and ous lymphocytic hypophysitis successfully treated with prednisone was prescribed. Symptoms improved but azathioprine. This treatment was applied empirically because recurred after the dose was reduced. Trans-sphenoidal of the failure of corticosteroids. To the best to our knowledge, surgery was attempted but the suprasellar portion of the this is the first case of lymphocytic hypophysitis in which mass could not be pulled through the pituitary fossa. such treatment has been attempted. The positive response to Histological examination confirmed the diagnosis of lympho- azathioprine suggests that further studies should be done to cytic hypophysitis.
    [Show full text]
  • HYPOPITUITARISM YOUR QUESTIONS ANSWERED Contents
    PATIENT INFORMATION HYPOPITUITARISM YOUR QUESTIONS ANSWERED Contents What is hypopituitarism? What is hypopituitarism? 1 What causes hypopituitarism? 2 The pituitary gland is a small gland attached to the base of the brain. Hypopituitarism refers to loss of pituitary gland hormone production. The What are the symptoms and signs of hypopituitarism? 4 pituitary gland produces a variety of different hormones: 1. Adrenocorticotropic hormone (ACTH): controls production of How is hypopituitarism diagnosed? 6 the adrenal gland hormones cortisol and dehydroepiandrosterone (DHEA). What tests are necessary? 8 2. Thyroid-stimulating hormone (TSH): controls thyroid hormone production from the thyroid gland. How is hypopituitarism treated? 9 3. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH): LH and FSH together control fertility in both sexes and What are the benefits of hormone treatment(s)? 12 the secretion of sex hormones (estrogen and progesterone from the ovaries in women and testosterone from the testes in men). What are the risks of hormone treatment(s)? 13 4. Growth hormone (GH): required for growth in childhood and has effects on the entire body throughout life. Is life-long treatment necessary and what precautions are necessary? 13 5. Prolactin (PRL): required for breast feeding. How is treatment followed? 14 6. Oxytocin: required during labor and delivery and for lactation and breast feeding. Is fertility possible if I have hypopituitarism? 15 7. Antidiuretic hormone (also known as vasopressin): helps maintain normal water Summary 15 balance. What do I need to do if I have a pituitary hormone deficiency? 16 Glossary inside back cover “Hypo” is Greek for “below normal” or “deficient” Hypopituitarism may involve the loss of one, several or all of the pituitary hormones.
    [Show full text]
  • Hypopituitarism Due to Lymphocytic Hypophysitis in a Patient with Retroperitoneal Fibrosis
    732 Alvarez, Cordido, Sacriscin Postgrad Med J: first published as 10.1136/pgmj.73.865.732 on 1 November 1997. Downloaded from Hypopituitarism due to lymphocytic hypophysitis in a patient with retroperitoneal fibrosis A Alvarez, F Cordido, F Sacristan Summary of 130/70 mmHg and body temperature of We present a 78-year-old woman with 37°C. Cardiopulmonary auscultation showed clinical acute hypopituitarism in whom a systolic murmur and bilateral rales. There pathologic findings showed lymphocytic was marked tenderness after percussion of the hypophysitis and retroperitoneal fibrosis. right costovertebral area. Laboratory blood Lymphocytic hypophysitis should be in- tests revealed an erythrocyte count of cluded in the differential diagnosis of 3.1 x 1012/1, haemoglobin 6.0 mmol/l, haema- hypopituitarism at any age. The associa- tocrit 0.267, leucocyte count 8.7 x 109/1, urea tion with idiopathic retroperitoneal fibro- 34.1 mmol/l, creatinine 335.9 mmol/l, potas- sis suggest an autoimmune origin for this sium 5.5 mmol/l, sodium 135 mmol/l and entity. glucose 6.1 mmol/l. The urinary sediment presented abundant white blood cells and Keywords: hypopituitarism, lymphocytic hypophysi- bacteria. Chest X-ray showed a right pleural tis, retroperitoneal fibrosis effusion. Renal sonogram showed bilateral nephrolithiasis, high-grade right obstructive uropathy, and atrophic right kidney. The Hypopituitarism is most frequently due to a initial diagnosis was urinary tract infection pituitary tumour, other common causes being complicating obstructive uropathy. Empiric surgery, pituitary radiation therapy and pitui- antibacterial treatment was prescribed (aztreo- tary apoplexy. Less common causes ofpituitary nam). Her condition worsened with vomiting, insufficiency include empty sella syndrome, progressive decline in mental status and head trauma, internal carotid artery aneurysm hypotension.
    [Show full text]
  • A Radiologic Score to Distinguish Autoimmune Hypophysitis from Nonsecreting Pituitary ORIGINAL RESEARCH Adenoma Preoperatively
    A Radiologic Score to Distinguish Autoimmune Hypophysitis from Nonsecreting Pituitary ORIGINAL RESEARCH Adenoma Preoperatively A. Gutenberg BACKGROUND AND PURPOSE: Autoimmune hypophysitis (AH) mimics the more common nonsecret- J. Larsen ing pituitary adenomas and can be diagnosed with certainty only histologically. Approximately 40% of patients with AH are still misdiagnosed as having pituitary macroadenoma and undergo unnecessary I. Lupi surgery. MR imaging is currently the best noninvasive diagnostic tool to differentiate AH from V. Rohde nonsecreting adenomas, though no single radiologic sign is diagnostically accurate. The purpose of this P. Caturegli study was to develop a scoring system that summarizes numerous MR imaging signs to increase the probability of diagnosing AH before surgery. MATERIALS AND METHODS: This was a case-control study of 402 patients, which compared the presurgical pituitary MR imaging features of patients with nonsecreting pituitary adenoma and controls with AH. MR images were compared on the basis of 16 morphologic features besides sex, age, and relation to pregnancy. RESULTS: Only 2 of the 19 proposed features tested lacked prognostic value. When the other 17 predictors were analyzed jointly in a multiple logistic regression model, 8 (relation to pregnancy, pituitary mass volume and symmetry, signal intensity and signal intensity homogeneity after gadolin- ium administration, posterior pituitary bright spot presence, stalk size, and mucosal swelling) remained significant predictors of a correct classification. The diagnostic score had a global performance of 0.9917 and correctly classified 97% of the patients, with a sensitivity of 92%, a specificity of 99%, a positive predictive value of 97%, and a negative predictive value of 97% for the diagnosis of AH.
    [Show full text]
  • Primary Empty Sella Syndrome: Characteristics of the Pituitary
    Full Text Article Open Access Original Article Primary empty sella syndrome: Characteristics of the pituitary deficiency. A bicentric case series. Belaid Rym 1,3*, Khiari Karima 1,3, Ouertani Haroun 2,3. 1: Department of Endocrinology Charles Nicolle’s Abstract: Hospital, Tunis, Tunisia 2: Department of Endocrinology Military Hospital, Tunis, Tunisia 3: College of medicine Tunis Tunisia Background and aim * Corresponding author Correspondence to: Empty sella is the neuroradiological or pathological finding of an [email protected] apparently empty sella turcica. The aim of the study was to analyze the Publication data: Submitted: January 2,2020 clinical, hormonal and radiological characteristics of patients with empty Accepted: February 28,2020 sella and to compare anterior pituitary function in total versus partial Online: March 15 ,2020 primary empty sella. This article was subject to full peer-review. Methods The records of 36 patients with primary empty sella were retrospectively analyzed over a 24-years period. The patients were evaluated for pituitary function with basal hormone levels (FT4, TSH, IGF1, FSH, LH, cortisol, ACTH, prolactin) and dynamic testing when necessary. Results Our study included 26 women and 10 men with an average age of 47.64 ±15.47 years. Seventy-six per cent of women were multiparous. Fifteen patients were obese. The revealing symptoms were dominated by endocrine signs (52.7%). More than half of our patients complained of headache. Sixty-one of the patients had partial empty sella and the remaining 39% had total empty sella. Two or more pituitary hormone deficiency were found in 41% of cases. Secondary adrenal insufficiency was the most common pituitary hormone deficiency(41.7%).The percentage of hypopituitarism in complete primary empty sella was significantly higher than that in partial primary empty sella (P<0.05).The management was based on hormone replacement therapy in case of hypopituitarism and on analgesic therapy in case of headache.
    [Show full text]
  • Sheehan's Syndrome and Lymphocytic Hypophysitis Fact Sheet for Patients
    1 Sheehan’s Syndrome and Lymphocytic Hypophysitis Fact sheet for patients Sheehan’s Syndrome and Lymphocytic Hypophysitis (LH) can present after childbirth, in similar ways. However, in Sheehan’s there is a history of profound blood loss and imaging of the pituitary will not show a mass lesion. In Lymphocytic Hypophysitis, there is normal delivery and post-partum, and it can be a month or more after delivery that symptoms start. An MRI in this instance may show a pituitary mass and thickened stalk. Management of Sheehan’s is appropriate replacement of hormones, in LH - replacement hormones and in some circumstances, steroids and surgical biopsy. The key of course is being seen by an endocrinologist with expertise in pituitary and not accepting the overwhelming features of hypopituitarism as just ‘normal’. If features of Diabetes Insipidus are present the diagnosis is usually easier, as severe thirst and passing copious amounts of urine will be present. Sheehan’s syndrome Sheehan’s syndrome is a rare condition in which severe bleeding during childbirth causes damage to the pituitary gland. The damage to pituitary tissue may result in pituitary hormone deficiencies (hypopituitarism), which can mean lifelong hormone replacement. What causes Sheehan’s syndrome? During pregnancy, an increased amount of the hormone oestrogen in the body causes an increase in the size of the pituitary gland and the volume of blood flowing through it. This makes the pituitary gland more vulnerable to damage from loss of blood. If heavy bleeding occurs during or immediately after childbirth, there will be a sudden decrease in the blood supply to the already vulnerable pituitary gland.
    [Show full text]
  • Lymphocytic Hypophysitis: Differential Diagnosis and Effects of High-Dose
    Case Study TheScientificWorldJOURNAL (2010) 10, 126–134 ISSN 1537-744X; DOI 10.1100/tsw.2010.24 Lymphocytic Hypophysitis: Differential Diagnosis and Effects of High-Dose Pulse Steroids, Followed by Azathioprine, on the Pituitary Mass and Endocrine Abnormalities — Report of a Case and Literature Review Lorenzo Curtò1,*, Maria L. Torre1, Oana R. Cotta1, Marco Losa2, Maria R. Terreni3, Libero Santarpia4, Francesco Trimarchi1, and Salvatore Cannavò1 1Department of Medicine and Pharmacology - Section of Endocrinology, University of Messina, Italy; 2Department of Neurosurgery and 3Department of Pathology, San Raffaele Scientific Institute, University Vita-Salute, Milan, Italy; 4Translational Research Unit, Department of Oncology, Hospital of Prato and Istituto Toscana Tumori, Florence, Italy E-mail: [email protected] Received September 26, 2009; Revised January 8, 2010; Accepted January 11, 2010; Published January 21, 2010 We report on a man with a progressively increasing pituitary mass, as demonstrated by MRI. It produced neurological and ophthalmological symptoms, and, ultimately, hypopituitarism. MRI also showed enlargement of the pituitary stalk and a dural tail phenomenon. An increased titer of antipituitary antibodies (1:16) was detected in the serum. Pituitary biopsy showed autoimmune hypophysitis (AH). Neither methylprednisolone pulse therapy nor a subsequent treatment with azathioprine were successful in recovering pituitary function, or in inducing a significant reduction of the pituitary mass after an initial, transient clinical and neuroradiological improvement. Anterior pituitary function evaluation revealed persistent hypopituitarism. AH is a relatively rare condition, particularly in males, but it represents an emerging entity in the diagnostic management of pituitary masses. This case shows that response to appropriate therapy for hypophysitis may not be very favorable and confirms that diagnostic management of nonsecreting pituitary masses can be a challenge.
    [Show full text]
  • A Case of Hypothalamic Panhypopituitarism with Empty Sella Syndrome: Case Report and Review of the Literature
    Endocrine Journal 2009, 56 (4), 585-589 A Case of Hypothalamic Panhypopituitarism with Empty Sella Syndrome: Case Report and Review of the Literature HISAKO KOMADA*, MASAAKI YAMAMOTO*, SAKI OKUBO*, KANTO NAGAI*, KEIJI IIDA*, TAKEHIRO NAKAMURA**, YUSHI HIROTA*, KAZUHIKO SAKAGUCHI*, MASATO KASUGA* AND YUTAKA TAKAHASHI* *Division of Diabetes, Metabolism, and Endocrinology, Department of Internal Medicine, Kobe University Graduate school of Medicine, Kobe, Japan **Kobe City Medical Center West Hospital, Kobe, Japan Abstract. Empty sella syndrome is frequently accompanied with pituitary dysfunction. Most of the patients with empty sella syndrome demonstrate primary pituitary or stalk dysfunction and few cases show hypothalamic dysfunction. A 71- year-old man manifested appetite loss, nausea and vomiting with hyponatremia and adrenal insufficiency. Hormonal evaluation and cranial MRI revealed a panhypopituitarism with empty sella. Intriguingly, while the response of ACTH to CRH administration was exaggerated, the response to insulin hypoglycemia was blunted. Serum PRL levels were normal. Further, decreased level of fT4, slightly elevated basal levels of TSH, and delayed response of TSH to TRH administration were observed. These findings strongly suggest that the panhypopituitarism is caused by hypothalamic dysfunction. The presence of autoantibodies to pituitary and cerebrum in the patient’s serum implies an autoimmune mechanism as a pathogenesis. Key words: Empty sella, Hypothalamic, Panhypopituitarism, Adrenal insufficiency, Autoimmune (Endocrine Journal 56: 585-589, 2009) EMPTY sella is characterized by the herniation of the lymphocytic hypophysitis [1-2]. subarachnoid space within the sella, which is often as- It has been reported that empty sella is present in sociated with some degree of flattening of the pitu- 5.5%-23% of autopsies [3].
    [Show full text]
  • Acromegaly with Empty Sella Syndrome
    ID: 21-0049 -21-0049 R Daya and others Acromegaly with empty sella ID: 21-0049; July 2021 syndrome DOI: 10.1530/EDM-21-0049 Acromegaly with empty sella syndrome Reyna Daya1,2 , Faheem Seedat 1,2, Khushica Purbhoo3, Saajidah Bulbulia1,2 and Zaheer Bayat1,2 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Helen Joseph Hospital, Rossmore, Johannesburg, South Africa, 2Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Correspondence Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa, and should be addressed 3Department of Nuclear Medicine and Molecular Imaging, Chris Hani Baragwanath Academic Hospital and Charlotte to F Seedat Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Email South Africa [email protected] Summary Acromegaly is a rare, chronic progressive disorder with characteristic clinical features caused by persistent hypersecretion of growth hormone (GH), mostly from a pituitary adenoma (95%). Occasionally, ectopic production of GH or growth hormone-releasing hormone (GHRH) with resultant GH hypersecretion may lead to acromegaly. Sometimes localizing thesourceofGHhypersecretionmayprovedifficult.Rarely,acromegalyhasbeenfoundinpatientswithanemptysella (ES) secondary to prior pituitary radiation and/or surgery. However, acromegaly in patients with primary empty sella (PES) is exceeding rarely and has only been described in a few cases. We describe a 47-year-old male who presented with overt features of acromegaly (macroglossia, prognathism, increased hand and feet size). Biochemically, both the serum GH (21.6 μg/L) and insulin-like growth factor 1 (635 μg/L) were elevated. In addition, there was a paradoxical elevation of GH following a 75 g oral glucose load.
    [Show full text]
  • Management of Hypopituitarism
    Journal of Clinical Medicine Review Management of Hypopituitarism Krystallenia I. Alexandraki 1 and Ashley B. Grossman 2,3,* 1 Endocrine Unit, 1st Department of Propaedeutic Medicine, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece; [email protected] 2 Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford OX3 7LE, UK 3 Centre for Endocrinology, Barts and the London School of Medicine, London EC1M 6BQ, UK * Correspondence: [email protected] Received: 18 November 2019; Accepted: 2 December 2019; Published: 5 December 2019 Abstract: Hypopituitarism includes all clinical conditions that result in partial or complete failure of the anterior and posterior lobe of the pituitary gland’s ability to secrete hormones. The aim of management is usually to replace the target-hormone of hypothalamo-pituitary-endocrine gland axis with the exceptions of secondary hypogonadism when fertility is required, and growth hormone deficiency (GHD), and to safely minimise both symptoms and clinical signs. Adrenocorticotropic hormone deficiency replacement is best performed with the immediate-release oral glucocorticoid hydrocortisone (HC) in 2–3 divided doses. However, novel once-daily modified-release HC targets a more physiological exposure of glucocorticoids. GHD is treated currently with daily subcutaneous GH, but current research is focusing on the development of once-weekly administration of recombinant GH. Hypogonadism is targeted with testosterone replacement in men and on estrogen replacement therapy in women; when fertility is wanted, replacement targets secondary or tertiary levels of hormonal settings. Thyroid-stimulating hormone replacement therapy follows the rules of primary thyroid gland failure with L-thyroxine replacement.
    [Show full text]
  • Empty Sella Syndrome As a Window Into the Neuroprotective Effects of Prolactin
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.30.403576; this version posted November 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. David A. Paul, MD, MS1; Emma Strawderman2; Alejandra Rodriguez, BS3; Ricky Hoang, BA3; Colleen L. Schneider, PhD2,3,4; Sam Haber, BS1; Benjamin L. Chernoff, MA4; Ismat Shafiq, MBBS5; Zoë R. Williams, MD1,6,7; G. Edward Vates, MD, PhD1; Bradford Z. Mahon, PhD1,4,7,8 Empty sella syndrome as a window into the neuroprotective effects of prolactin 1Department of Neurosurgery, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642, USA 2Department of Brain and Cognitive Sciences, University of Rochester, Meliora Hall, 500 Wilson Blvd., Rochester, NY 14627, USA 3University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave., Rochester, NY 14642, USA 4Department of Psychology, Carnegie Mellon University, Baker Hall, 4909 Frew St., Pittsburgh, PA 15213, USA 5Department of Endocrinology and Metabolism, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642, USA 6Department of Ophthalmology, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642, USA 7Department of Neurology, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642, USA 8Neuroscience Institute, Carnegie Mellon University, 4909 Frew St., Pittsburgh, PA 15213, USA Corresponding Author: Bradford Z. Mahon Department of Psychology Carnegie Mellon University, Baker Hall Pittsburgh, PA 15213, USA. E-mail: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.11.30.403576; this version posted November 30, 2020.
    [Show full text]
  • Hypophysitis
    3 179 M N Joshi and others Hypophysitis 179:3 R151–R163 Review MECHANISMS IN ENDOCRINOLOGY Hypophysitis: diagnosis and treatment Mamta N Joshi1, Benjamin C Whitelaw2,3 and Paul V Carroll1,3 Correspondence 1Department of Endocrinology, Guy’s & St. Thomas’ NHS Foundation Trust, London, UK, 2Department of should be addressed Endocrinology, Kings College Hospital NHS Foundation Trust, London, UK, and 3Faculty of Life Sciences & Medicine, to P V Carroll King’s College Hospital London, London, UK Email [email protected] Abstract Hypophysitis is a rare condition characterised by inflammation of the pituitary gland, usually resulting in hypopituitarism and pituitary enlargement. Pituitary inflammation can occur as a primary hypophysitis (most commonly lymphocytic, granulomatous or xanthomatous disease) or as secondary hypophysitis (as a result of systemic diseases, immunotherapy or alternative sella-based pathologies). Hypophysitis can be classified using anatomical, histopathological and aetiological criteria. Non-invasive diagnosis of hypophysitis remains elusive, and the use of currently available serum anti-pituitary antibodies are limited by low sensitivity and specificity. Newer serum markers such as anti-rabphilin 3A are yet to show consistent diagnostic value and are not yet commercially available. Traditionally considered a very rare condition, the recent recognition of IgG4-related disease and hypophysitis as a consequence of use of immune modulatory therapy has resulted in increased understanding of the pathophysiology of hypophysitis. Modern imaging techniques, histological classification and immune profiling are improving the accuracy of the diagnosis of the patient with hypophysitis. The objective of this review is to bring readers up-to- date with current understanding of conditions presenting as hypophysitis, focussing on recent advances and areas for future development.
    [Show full text]